InvestorsHub Logo

rocketeer357

06/14/09 7:18 AM

#27215 RE: Jagman #27214

Not an accurate indicator of success, to be sure, but it's better than seeing insiders bailing.

Many sub 1$ health/biotech/device companies hit rock bottom earlier this year and have amazingly rocketed to prices unimaginable in March. They have much bigger debt loads than CTGI and products with a much more limited scope.

They also have excitement, usually in the form of an FDA application about to be decided, a JV on the front burner or encouraging results from an early phase trial. The sector has been white hot. Check out the 3 month and the 5 day on NEPH, for example.

Unfortunately, CTGI currently generates the excitement of a stale cheese fart. We can only hope that there's some substantial negotiations quietly occurring, and that our poster boys, Frank and Richard, are leading the proceedings. They have the experience and the connections in the industry, and signing them up is one thing DR should get credit for.

If they're still ACTIVE with CTGI, we have a shot. If they've sold their positions and moved on.......well, let's hope that isn't the case....lol.

sojourner

06/14/09 2:47 PM

#27216 RE: Jagman #27214

The supreme irony is that had members of the management team filed to sell some shares during/after the big run-up, more shareholders than otherwise would have been inclined to follow suit and bank profits or free shares.

As it was, management stoically purchased shares come hell or high water thereby telegraphing to stockholders a false and deadly message that all was well.

As Mr. Ripley would say: "Believe it or not!"

otterman

06/15/09 11:08 AM

#27222 RE: Jagman #27214

Not true at all. Most stinky pinkies go down the drain by way of becoming bloated pigs with the company issuing free shares to management for 'services rendered'. Even selling these shares at subpenny brings them a profit. Ive never understood the logic myself but thats another story. CTGI by no means falls into this category.